Ligand · TKA
TKA · (1R,3R,7E,17beta)-17-{(2R,6S)-6-hydroxy-6-[(3S,5S,7S)-tricyclo[3.3.1.1~3,7~]dec-1-yl]hex-4-yn-2-yl}-2-methylidene-9,10-secoestra-5,7-diene-1,3-diol
TKA, (1R,3R,7E,17beta)-17-{(2R,6S)-6-hydroxy-6-[(3S,5S,7S)-tricyclo[3.3.1.1~3,7~]dec-1-yl]hex-4-yn-2-yl}-2-methylidene-9,10-secoestra-5,7-diene-1,3-diol (C35 H50 O3, 518.8 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records…
- Component
- TKA
- Formula
- C35 H50 O3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
TKA in 2 structures; the first of them:
- 3VTB · Crystal structure of rat vitamin D receptor bound to a partial agonist… · TKA A500 · binds TYR143, TYR147, PHE150, LEU223, LEU226, ALA227, LEU229, VAL230 and 21 more
- 3VTB · Crystal structure of rat vitamin D receptor bound to a partial agonist… · TKA A500 · binds TYR143, TYR147, PHE150, LEU223, LEU226, ALA227, LEU229, VAL230 and 21 more
Residues it binds most
LEU 2, TYR 2, SER 2, VAL 2, ALA 2, HIS 2, ILE 2, PHE 2, ARG 2, CYS 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.